Sign in
Companies / ILMN vs RVTY

ILMN vs RVTY: Illumina and Revvity

Life Sciences Tools
Compare more companies

Illumina (ILMN) reported $4.3B in revenue against a 19.6% net margin, while Revvity (RVTY) reported $2.9B at a 8.4% net margin, most recently.

MetricILMNRVTY
Revenue$4.3B$2.9B
Net Income$0.8B$0.2B
Gross Margin66.1%—
Operating Margin18.6%12.5%
EPS (Diluted)$5.45$2.07
Free Cash Flow$0.9B$0.5B
Total Debt$2.0B$3.2B
P/E Ratio24.8×46.7×
P/B Ratio7.6×1.5×
Stock Price$207.96$150.88
Free: last 5 years
Fiscal yearFY2008 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2021FY2022FY2023FY2024FY2025
ILMN Revenue••••••••••••••••••••••••••••••••••••••••••••••••••$3.2B$4.5B$4.5B$4.4B$4.3B
RVTY Revenue••••••••••••••••••••••••••••••••••••••••••••••••••$3.8B$3.8B$2.8B$2.8B$2.9B

More on ILMN

More on RVTY

Other comparisons